Show simple item record

dc.contributor.authorJones, Angus G.en
dc.contributor.authorShields, Beverleyen
dc.contributor.authorHyde, C. J.en
dc.contributor.authorHenley, W. E.en
dc.contributor.authorHattersley, Andrew T.en
dc.date.accessioned2016-08-12T09:33:37Z
dc.date.available2016-08-12T09:33:37Z
dc.date.issued2014
dc.identifier.citationIdentifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine. 2014, 9 (10):e111235 PLoS ONEen
dc.identifier.issn1932-6203
dc.identifier.pmid25340784
dc.identifier.doi10.1371/journal.pone.0111235
dc.identifier.urihttp://hdl.handle.net/11287/618284
dc.description.abstractDefining responders to glucose lowering therapy can be important for both clinical care and for the development of a stratified approach to diabetes management. Response is commonly defined by either HbA1c change after treatment or whether a target HbA1c is achieved. We aimed to determine the extent to which the individuals identified as responders and non-responders to glucose lowering therapy, and their characteristics, depend on the response definition chosen.en
dc.language.isoenen
dc.publisherPLoSen
dc.relation.urlhttp://dx.plos.org/10.1371/journal.pone.0111235en
dc.rightsArchived with thanks to PloS oneen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.titleIdentifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine.en
dc.typeJournal Articleen
dc.typeObservational Studyen
dc.typeResearch Support, Non-U.S. Gov'ten
dc.identifier.journalPloS Oneen
dc.description.noteThis article is freely available online via Open Access. Click on the 'Additional Link' above to access the full text.en
dc.type.versionPublisheden


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record